New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) suggests that ...

Suni Lee Pens Emotional Essay About Her Incurable Kidney Disease: 'I Will Never Be the Same Suni' Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

The Mediterranean diet has tons of benefits. Find out why the Mediterranean diet may be especially good as you age.

XRP price may be headed for a rally after Standard Chartered predicted that it might reach $5.50 by the end of 2025. The ...

The upside comes after Lexicon lands a deal worth $1 billion for its experimental obesity drug with Novo Nordisk.

Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...

From a technical view, the market completed an expected retracement from the October 2022 lows. Read more here.

It outperformed Orexigen's Mysimba/Contrave weight loss drug, where around a quarter of patients in a phase 3 trial achieved the target ... the efficacy and safety data across previous Gelesis ...